← Back to Screener
OSR Holdings, Inc. Common Stock (OSRH)
Price$0.55
Favorite Metrics
Price vs S&P 500 (26W)-18.85%
Price vs S&P 500 (4W)20.36%
Market Capitalization$18.11M
All Metrics
Book Value / Share (Quarterly)$3.46
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.16
Price vs S&P 500 (YTD)-5.74%
Gross Margin (TTM)20.40%
Net Profit Margin (TTM)-619.82%
EPS (TTM)$-1.31
10-Day Avg Trading Volume0.81M
EPS Excl Extra (TTM)$-1.31
EPS (Annual)$-0.92
ROI (Annual)-21.97%
Gross Margin (Annual)20.40%
Cash / Share (Quarterly)$0.09
ROA (Last FY)-10.52%
EBITD / Share (TTM)$-1.52
Operating Margin (TTM)-631.01%
Cash Flow / Share (Annual)$-1.02
P/B Ratio0.23x
P/B Ratio (Quarterly)0.19x
EV / Revenue (TTM)7.14x
Net Interest Coverage (TTM)-64.31x
ROA (TTM)-10.17%
EPS Incl Extra (Annual)$-0.92
Current Ratio (Annual)0.16x
Quick Ratio (Quarterly)0.15x
3-Month Avg Trading Volume1.27M
52-Week Price Return-65.41%
P/S Ratio (Annual)6.23x
Asset Turnover (Annual)0.02x
52-Week High$1.79
EPS Excl Extra (Annual)$-0.92
26-Week Price Return-14.86%
Quick Ratio (Annual)0.15x
13-Week Price Return-23.73%
Total Debt / Equity (Annual)0.06x
Current Ratio (Quarterly)0.16x
Enterprise Value$20.749
Asset Turnover (TTM)0.02x
Pretax Margin (Annual)-994.16%
Cash / Share (Annual)$0.18
3-Month Return Std Dev97.98%
ROE (Last FY)-23.20%
Net Interest Coverage (Annual)-64.31x
EPS Basic Excl Extra (Annual)$-0.92
Total Debt / Equity (Quarterly)0.06x
EPS Incl Extra (TTM)$-1.31
ROI (TTM)-21.40%
P/S Ratio (TTM)6.23x
Revenue / Share (Annual)$0.15
Price vs S&P 500 (52W)-95.24%
Year-to-Date Return-3.10%
5-Day Price Return7.03%
EPS Normalized (Annual)$-0.92
ROA (5Y Avg)-3.71%
Net Profit Margin (Annual)-619.82%
Month-to-Date Return-9.35%
EBITD / Share (Annual)$-1.46
Operating Margin (Annual)-631.01%
LT Debt / Equity (Annual)0.00x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-1.31
P/B Ratio (Annual)0.19x
Inventory Turnover (TTM)4.14x
Pretax Margin (TTM)-994.16%
Book Value / Share (Annual)$66.45
Price vs S&P 500 (13W)-24.42%
Beta0.49x
Revenue / Share (TTM)$0.11
ROE (TTM)-22.58%
52-Week Low$0.38
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.14
4.14
4.14
4.14
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
OSRHOSR Holdings, Inc. Common Stock | 6.23x | — | 20.40% | -631.01% | $0.55 |
SYKStryker Corporation | 5.15x | 11.84% | 64.57% | 19.43% | $338.38 |
BSXBoston Scientific Corp. | 4.76x | 15.16% | 69.01% | 18.00% | $63.42 |
MMM3M Company | 3.18x | -4.97% | 39.92% | 18.55% | $150.55 |
MDLNMedline Inc. Class A common stock | 2.21x | — | 26.44% | 7.78% | $46.94 |
BDXBecton, Dickinson and Co. | 2.01x | 6.32% | 46.42% | 12.15% | $154.82 |
RMDResMed Inc. | 6.06x | 11.72% | 60.85% | 33.70% | $224.72 |
DXCMDexCom, Inc. | 5.23x | 19.33% | 62.09% | 19.56% | $61.23 |
WSTWest Pharmaceutical Services, Inc. | 6.22x | 7.44% | 35.91% | 19.03% | $269.81 |
PODDInsulet Corporation | 5.31x | 24.53% | 71.63% | 12.92% | $201.47 |
PENPenumbra, Inc. | 9.31x | 20.16% | 67.14% | 13.48% | $331.47 |
About
OSR Holdings Inc operates in three healthcare segments: oral immunotherapy development for cancer, design-augmented biologics for age-related and degenerative diseases, and neurovascular medical device distribution in Korea. The company develops and commercializes therapeutic and medical device solutions to improve patient outcomes.